Serum Carotenoids and Risk of Gastrointestinal Tract Cancer: Meta-analysis of Ten Studies

Yong Zhou

Status: Completed

Conditions: Gastrointestinal Tract Cancer

Treatments: Other: serum carotenoids

Study type: Observational

Funder types: Other

Identifiers

NCT03433092

2759067085

Details and patient eligibility

About

Previous studies have suggested that serum carotenoids may be associated with risk of gastrointestinal tract cancer (GIT cancer), but the results were inconsistent. Thus, the investigators conducted a meta-analysis to evaluate the associations between serum carotenoids and risk of GIT cancer.

Enrollment: 40,641 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The study had both case and control groups
• Serum carotenoids levels, relative risk (RR) or OR and corresponding 95% CI were reported
• Patients in case group were diagnosed with GIT cancer

Exclusion criteria

·Animal studies

Trial design

40,641 participants in 10 patient groups

Jing Huang et. al, 2017

Treatment:

Other: serum carotenoids

Max Leenders et. al,2014

Treatment:

Other: serum carotenoids

Yusuke Okuyama et. al,2014

Treatment:

Other: serum carotenoids

GC Kabat et. al,2012

Treatment:

Other: serum carotenoids

Christina Persson et. al,2008

Treatment:

Other: serum carotenoids

M Jenab et. al,2006

Treatment:

Other: serum carotenoids

Kenji Wakai et. al,2005

Treatment:

Other: serum carotenoids

Christian C. Abnet et. al,2003

Treatment:

Other: serum carotenoids

N Malila et. al,2002

Treatment:

Other: serum carotenoids

G Pappalardo et. al,1997

Treatment:

Other: serum carotenoids